Pine Valley Investments Ltd Liability Co Has $549,000 Stock Holdings in Humana Inc. (NYSE:HUM)

Pine Valley Investments Ltd Liability Co trimmed its stake in Humana Inc. (NYSE:HUM - Free Report) by 85.9% during the third quarter, according to its most recent disclosure with the SEC. The fund owned 1,728 shares of the insurance provider's stock after selling 10,535 shares during the quarter. Pine Valley Investments Ltd Liability Co's holdings in Humana were worth $549,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of the company. PDT Partners LLC increased its position in Humana by 190.0% in the 3rd quarter. PDT Partners LLC now owns 4,060 shares of the insurance provider's stock valued at $1,286,000 after acquiring an additional 2,660 shares during the period. Ontario Teachers Pension Plan Board grew its stake in shares of Humana by 6.5% in the third quarter. Ontario Teachers Pension Plan Board now owns 1,173,535 shares of the insurance provider's stock worth $371,705,000 after purchasing an additional 71,910 shares in the last quarter. Swedbank AB grew its stake in shares of Humana by 3.0% in the third quarter. Swedbank AB now owns 105,976 shares of the insurance provider's stock worth $33,567,000 after purchasing an additional 3,085 shares in the last quarter. Heritage Oak Wealth Advisors LLC acquired a new position in shares of Humana during the second quarter valued at $3,456,000. Finally, Charles Schwab Investment Management Inc. raised its stake in shares of Humana by 3.0% during the third quarter. Charles Schwab Investment Management Inc. now owns 899,191 shares of the insurance provider's stock valued at $284,810,000 after purchasing an additional 26,056 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company's stock.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the stock. Sanford C. Bernstein upgraded shares of Humana from a "market perform" rating to an "outperform" rating and set a $308.00 target price for the company in a research report on Tuesday, October 8th. Stephens reiterated an "equal weight" rating and set a $250.00 price objective on shares of Humana in a research note on Wednesday, October 9th. UBS Group cut their target price on Humana from $380.00 to $250.00 and set a "neutral" rating for the company in a research report on Friday, October 4th. Royal Bank of Canada lowered their price target on Humana from $400.00 to $265.00 and set an "outperform" rating on the stock in a research report on Tuesday, October 8th. Finally, Piper Sandler lowered Humana from an "overweight" rating to a "neutral" rating and cut their price objective for the company from $392.00 to $274.00 in a report on Thursday, October 3rd. Twenty investment analysts have rated the stock with a hold rating and six have given a buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $304.15.

Humana Stock Up 0.5 %

Shares of Humana stock traded up $1.34 during trading on Friday, hitting $274.12. 1,383,466 shares of the stock traded hands, compared to its average volume of 1,841,710. The company has a fifty day moving average price of $274.13 and a two-hundred day moving average price of $324.70. Humana Inc. has a twelve month low of $213.31 and a twelve month high of $486.00. The stock has a market cap of $33.01 billion, a P/E ratio of 24.28, a PEG ratio of 2.15 and a beta of 0.53. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76.

Humana (NYSE:HUM - Get Free Report) last posted its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.48 by $0.68. Humana had a net margin of 1.18% and a return on equity of 13.20%. The firm had revenue of $29.30 billion during the quarter, compared to analysts' expectations of $28.66 billion. Equities research analysts predict that Humana Inc. will post 16.14 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be given a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 1.29%. The ex-dividend date of this dividend is Tuesday, December 31st. Humana's payout ratio is 31.36%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.